Skip to main content
Clinical Trials/NL-OMON47432
NL-OMON47432
Not yet recruiting
Not Applicable

Cerebrospinal Fluid and Psychiatric Disorders (CSFPsych) - Cerebrospinal Fluid and Psychiatric Disorders

niversitair Medisch Centrum Utrecht0 sites500 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
500
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • A DSM\-IV or 5 classification of schizophrenia, schizophreniform disorder, schizoaffective disorder (both depressive and bipolar types), psychosis not otherwise specified (or other unspecified psychotic disorders), major depressive disorder (with and without psychotic features), bipolar disorder (with and without current psychotic features or a history of psychotic features) and psychosis during the peripartum period (8 weeks after giving birth).

Exclusion Criteria

  • Patients with a psychotic or affective disorder:
  • Subjects meeting any of the following criteria will be excluded from participation in this study:
  • \-Lumbar\-puncture specific (relative) contra\-indications, again abiding by the UMCU protocol for LPs (see \*C1\_Addendum\_bij\_Onderzoeksprotocol\_Werkdocument Lumbaal punctie\_herzien april 2015\.pdf\*): a history of a severe adverse reaction to a previous lumbar puncture (reported by the subject and/or evident from the medical record, including post\-puncture headache), the use of anticoagulant agents, thrombocytopenia, local infection of the skin, clinical signs of raised intracranial pressure or a suspected spinal epidural abscess.
  • \- Although clotting abnormalities and suspected bacteraemia do not constitute contraindications for LPs, patients suffering from these will be excluded to avoid risks of excessive bleeding and infections.
  • \- Patients who are not mentally competent and who don't have decisional capacity to decide about participation in this study will not be included. Doctors assess mental competence and decisional capacity of patients to ascertain whether they are able to express a choice, understand and appreciate the information provided and reason about their possible participation. If there is any doubt about their mental competency or decisional capacity, the patient will not be included.
  • \- Patients who were admitted to a psychiatric unit involuntarily after being given an \*inbewaringstelling\* (IBS) will not be included. Patients with \*rechterlijke machtigingen\* (RM) may be included, but only if they are mentally competent (see section on mental competence and decisional capacity above). The reasons for including the latter category of patients is that the inclusion of these patients will contribute to assembling a study population representative of all Dutch psychotic disorder patients.
  • \- Some patients may participate in other studies as well. In those instances, the researchers of both studies discuss the option of simultaneous enrollment and decide about inclusion of the patient. Any decision about participation of patients in two studies will be based on balancing the advantages of dual study participation with the burden of such participation for participants. ;Healthy controls
  • Subjects meeting any of the following criteria will be excluded from participation in this study:
  • \- A current or past history of self\-reported major psychiatric or neurological illness.
  • \- Lumbar\-puncture specific (relative) contra\-indications: the anesthesiologist assesses these during routine pre\-operative screening.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Cerebrospinal Fluid Analysis in Psychiatry - Multicentric, prospective patient registry for cerebrospinal fluid analysis in psychiatric patientsICD-10 F*: Mental and behavioral disordersincl. planned lumbar punctureICD-10patients who receive a lumbar puncture as part of a neurological exclusion diagnosis
DRKS00024041Klinik für Psychiatrie, Sozialpsychiatrie und Psychotherapie, Medizinische Hochschule Hannover200
Completed
Not Applicable
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System Diseases
ISRCTN34007592Trinity Translational Medicine Institute12
Recruiting
Not Applicable
Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.Cerebrospinal Fluid
NCT03656016Assiut University87
Terminated
Not Applicable
Cerebrospinal Fluid Collection and Repository StorageNervous System Diseases
NCT01862107National Institute of Neurological Disorders and Stroke (NINDS)51
Active, not recruiting
Not Applicable
Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte®) after intrathecal administration in children with malignant brain tumors and leptomeningeal disseminatioTo measure concentrations of liposomal cytarabine in CSF and plasma over time after intrathecal administration of liposomal cytarabine in children of different age groups with a malignant brain tumor and leptomenigeal dissemination. Measurements of concentrations of cytarabine after intrathecal administration of liposomal cytarabine will help to ensure proper dosage of liposomal cytarabine in small children, avoiding neurotoxic events and subtherapeutic drug levels.
EUCTR2006-004982-32-ATMedical University of Vienna, Department of Pedatrics